Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 and nab-paclitaxel in unresectable locally advanced pancreatic cancer
NCT03585062Phase 2Terminated
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Nov 2017
- Primary completion
- Jul 2019
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur, nab-paclitaxel in pancreatic cancer (PC), sponsored by Zhejiang Provincial People's Hospital. Started Nov 2017; status: terminated.
02
Drugs
tegafurnab-paclitaxel
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT03585062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03585062.